← Leaderboards
Laurie E Littlepage
University Of California San Francisco
$1,916,793
Attributed
$1,916,793
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $368.2K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,916,793 · 2
By mechanism
R01$1,785,821 · 1
F32$130,972 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Sunil D Kapila$6,386,827
- Zena Werb$33,582,689
- Nirao Mahesh Shah$25,020,886
- Helene S Smith$1,267,113
- Gordon B. Mills$27,749,983
Others in their field
Top investigators on “Mammary Gland”
- Jeffrey Rosen · Baylor College Of Medicine$19,572,228
- Lewis A Chodosh · University Of Pennsylvania$17,627,328
- Zena Werb · University Of California San Francisco$15,282,178
- Stanley R Hamilton · Johns Hopkins University$15,095,357
- John J Wysolmerski · Yale University$14,975,740
- Bert W O'Malley · Baylor College Of Medicine$14,351,952
Research focus
Mammary GlandCoculture TechniquesBreast Cancer PatientChemokineAttenuatedAnimal ModelAnimalsBisphosphonateArchitectureBoneBone NeoplasmsBone RemodelingBreast Cancer CellBreast Cancer MetastasisClinical TrialsBindingCancer CellCancer EtiologyCaringBlood VesselsCell ProliferationCellsCessation Of LifeCombined Modality Therapy
Grant awards (8)
CXCL5/CXCR2 axis as a therapeutic vulnerability of breast cancer metastasis to bone$357,994
R01 · FY2025 · CA · contact PI
CXCL5/CXCR2 axis as a therapeutic vulnerability of breast cancer metastasis to bone$368,165
R01 · FY2024 · CA · contact PI
CXCL5/CXCR2 axis as a therapeutic vulnerability of breast cancer metastasis to bone$350,834
R01 · FY2023 · CA · contact PI
CXCL5/CXCR2 axis as a therapeutic vulnerability of breast cancer metastasis to bone$350,834
R01 · FY2022 · CA · contact PI
CXCL5/CXCR2 axis as a therapeutic vulnerability of breast cancer metastasis to bone$357,994
R01 · FY2021 · CA · contact PI
MMPs &Genomic Instability in Mammary Tumor Development$48,296
F32 · FY2005 · CA
MMPs &Genomic Instability in Mammary Tumor Development$42,976
F32 · FY2004 · CA
MMPs &Genomic Instability in Mammary Tumor Development$39,700
F32 · FY2003 · CA